Literature DB >> 6423188

Persistence of rubella antibody 8-18 years after vaccination.

S O'Shea, J M Best, J E Banatvala, W C Marshall, J A Dudgeon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6423188      PMCID： PMC1442668          DOI： 10.1136/bmj.288.6423.1043

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Rubella viraemia and antibody responses after rubella vaccination and reimmunization.

Authors:  H H Balfour; K E Groth; C K Edelman; D P Amren; J M Best; J E Banatvala
Journal:  Lancet       Date:  1981-05-16       Impact factor: 79.321

2.  Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories.

Authors:  J B Kurtz; P P Mortimer; P R Mortimer; P Morgan-Capner; M S Shafi; G B White
Journal:  J Hyg (Lond)       Date:  1980-04

3.  Rubella immunity by four different techniques: results of challenge studies.

Authors:  J M Best; G C Harcourt; A Druce; S J Palmer; S O'Shea; J E Banatvala
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

4.  Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus.

Authors:  S O'Shea; J M Best; J E Banatvala
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

5.  Rubella vaccination: persistence of antibodies for up to 16 years.

Authors:  S O'Shea; J M Best; J E Banatvala; W C Marshall; J A Dudgeon
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24
  5 in total
  9 in total

Review 1.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

Review 2.  Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.

Authors:  S E Robertson; F T Cutts; R Samuel; J L Diaz-Ortega
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  Scandinavian model for eliminating measles, mumps, and rubella.

Authors:  E Rabo; J Taranger
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-24

4.  Duration of the immune response to MMR vaccine in children of two age-different groups.

Authors:  S Li Volti; G Giammanco-Bilancia; M Grassi; R Garozzo; R Gluck; G Giammanco
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

5.  Possibility of reinfection after immunisation with RA27/3 live attenuated rubella virus.

Authors:  M G Cusi; P E Valensin; C Cellesi
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Rubella: immunity and vaccination in schoolgirls.

Authors:  G Kudesia; E T Robinson; W D Wilson; T S Wilson; I M Stewart; A T Campbell; W Thomson; M Silver; D Reid; G E Urquhart
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

7.  Rubella epidemiology in South East England.

Authors:  D J Nokes; R M Anderson; M J Anderson
Journal:  J Hyg (Lond)       Date:  1986-04

8.  Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.

Authors:  R M Anderson; B T Grenfell
Journal:  J Hyg (Lond)       Date:  1986-04

9.  Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.

Authors:  M Böttiger; B Christenson; V Romanus; J Taranger; A Strandell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.